134217-15-5Relevant articles and documents
ANTI-HEPATITIS B VIRUS AGENT
-
, (2021/08/13)
The present disclosure provides an anti-hepatitis B virus agent and a prophylactic or therapeutic agent for hepatitis B virus-related diseases, each comprising a nucleic acid analogue as an active ingredient. The problem can be solved by 2'-deoxy-2'-fluoro-β-2-fluoro-D-adenosine or its prodrug, or a pharmaceutically acceptable salt thereof, or a solvate thereof.
2'-fluoro-2-haloarabinoadinosines and their pharmaceutical compositions
-
, (2008/06/13)
The present invention is directed to certain 2'-fluoro, 2-substituted purine nucleosides which are toxic to cancerous cell lines.